Income Statement EKF Diagnostics Holdings plc
Equities
EKF
GB0031509804
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
29.03 GBX | +1.14% | +3.85% | -8.29% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 44.92M | 65.26M | 81.84M | 66.64M | 52.61M | |||||
Total Revenues | 44.92M | 65.26M | 81.84M | 66.64M | 52.61M | |||||
Cost of Goods Sold, Total | 21.19M | 27.84M | 42.47M | 35.82M | 28.18M | |||||
Gross Profit | 23.73M | 37.42M | 39.37M | 30.81M | 24.44M | |||||
Selling General & Admin Expenses, Total | 12.67M | 16.87M | 11.24M | 16.42M | 14.13M | |||||
R&D Expenses | 2.3M | 1.4M | 1.4M | 1.52M | 1.82M | |||||
Depreciation & Amortization - (IS) | 720K | 926K | 1.19M | 1.74M | 1.65M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 2.93M | 2.75M | 3.79M | 3.5M | 2.07M | |||||
Other Operating Expenses | -337K | -133K | -90K | -919K | -158K | |||||
Other Operating Expenses, Total | 18.28M | 21.81M | 17.52M | 22.26M | 19.52M | |||||
Operating Income | 5.45M | 15.61M | 21.84M | 8.55M | 4.91M | |||||
Interest Expense, Total | -58K | -76K | -68K | -102K | -75K | |||||
Interest And Investment Income | 73K | 53K | 45K | 131K | 125K | |||||
Net Interest Expenses | 15K | -23K | -23K | 29K | 50K | |||||
Other Non Operating Income (Expenses) | -281K | -1.52M | -289K | - | - | |||||
EBT, Excl. Unusual Items | 5.18M | 14.07M | 21.53M | 8.58M | 4.96M | |||||
Restructuring Charges | -29K | -58K | -37K | -17.53M | -2.83M | |||||
Merger & Related Restructuring Charges | - | - | -164K | - | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Asset Writedown | - | - | - | - | - | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | 367K | 1.34M | 106K | 2K | - | |||||
EBT, Incl. Unusual Items | 5.52M | 15.36M | 21.44M | -8.94M | 2.13M | |||||
Income Tax Expense | 1.59M | 3.97M | 5.28M | 634K | -600K | |||||
Earnings From Continuing Operations | 3.93M | 11.38M | 16.16M | -9.58M | 2.73M | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 3.93M | 11.38M | 16.16M | -9.58M | 2.73M | |||||
Minority Interest | -254K | -271K | -307K | -525K | -379K | |||||
Net Income - (IS) | 3.68M | 11.11M | 15.85M | -10.1M | 2.35M | |||||
Net Income to Common Incl Extra Items | 3.68M | 11.11M | 15.85M | -10.1M | 2.35M | |||||
Net Income to Common Excl. Extra Items | 3.68M | 11.11M | 15.85M | -10.1M | 2.35M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.01 | 0.02 | 0.03 | -0.02 | 0.01 | |||||
Basic EPS - Continuing Operations | 0.01 | 0.02 | 0.03 | -0.02 | 0.01 | |||||
Basic Weighted Average Shares Outstanding | 454M | 455M | 457M | 457M | 454M | |||||
Net EPS - Diluted | 0.01 | 0.02 | 0.03 | -0.02 | 0.01 | |||||
Diluted EPS - Continuing Operations | 0.01 | 0.02 | 0.03 | -0.02 | 0.01 | |||||
Diluted Weighted Average Shares Outstanding | 458M | 459M | 461M | 457M | 454M | |||||
Normalized Basic EPS | 0.01 | 0.02 | 0.03 | 0.01 | 0.01 | |||||
Normalized Diluted EPS | 0.01 | 0.02 | 0.03 | 0.01 | 0.01 | |||||
Dividend Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Payout Ratio | - | 40.94 | 32.19 | -54.04 | 231.51 | |||||
Supplemental Items | ||||||||||
EBITDA | 9.04M | 19.49M | 26.46M | 13.16M | 9.25M | |||||
EBITA | 7.86M | 18.13M | 25.03M | 11.08M | 6.69M | |||||
EBIT | 5.45M | 15.61M | 21.84M | 8.55M | 4.91M | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 28.74 | 25.86 | 24.62 | -7.09 | -28.16 | |||||
Total Current Taxes | 2M | 4M | 5.19M | 2.88M | -1.55M | |||||
Total Deferred Taxes | -416K | -31K | 85K | -2.24M | 947K | |||||
Normalized Net Income | 2.98M | 8.53M | 13.15M | 4.84M | 2.72M | |||||
Interest on Long-Term Debt | 58K | 46K | 67K | 56K | 28K | |||||
Supplemental Operating Expense Items | ||||||||||
General and Administrative Expenses | 12.67M | 16.87M | 11.24M | 16.42M | 14.13M | |||||
Research And Development Expense From Footnotes | 2.78M | 1.69M | 1.93M | 2.6M | 2.84M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., G&A Exp. (Total) | 2.12M | 5.29M | -1.24M | -308K | -2K | |||||
Stock-Based Comp., Other (Total) | - | - | -5.35M | - | - | |||||
Total Stock-Based Compensation | 2.12M | 5.29M | -6.59M | -308K | -2K |